XML 48 R37.htm IDEA: XBRL DOCUMENT v3.24.0.1
Share-based Compensation (Tables)
12 Months Ended
Dec. 31, 2023
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Summary of Recognition of Share-Based Compensation related to Employees

Share-based compensation expense is recognized in cost of services, product and technology expense, and selling, general, and administrative expense, in the accompanying consolidated statements of operations and comprehensive income as follows (in thousands):

 

Year Ended December 31,

 

 

2023

 

 

2022

 

 

2021

 

Share-based compensation expense

 

 

 

 

 

 

 

 

 

Cost of services

 

$

1,279

 

 

$

1,103

 

 

$

163

 

Product and technology expense

 

 

2,246

 

 

 

1,351

 

 

 

459

 

Selling, general, and administrative expense

 

 

11,740

 

 

 

5,402

 

 

 

8,908

 

Total share-based compensation expense

 

$

15,265

 

 

$

7,856

 

 

$

9,530

 

Prior to the IPO, all share-based awards were issued by Fastball Holdco, L.P., the Company’s previous parent company, under individual grant agreements and the partnership agreement of such parent company under the 2020 Equity Plan. In connection with the IPO, the Company adopted the 2021 Equity Plan.

Summary of Assumptions Applied to Establish Fair Value of Options Granted Using Black-Scholes Option Pricing Model The fair value of the modified stock options was estimated on the date of modification using the Black-Scholes option-pricing model with the following weighted average assumptions:

 

 

Options

 

Expected stock price volatility

 

 

37.43

%

Risk-free interest rate

 

 

3.40

%

Expected term (in years)

 

 

4.67

 

Fair-value of the underlying unit

 

$

12.61

 

Summary of outstanding stock option grants issued

 

 

 

Options

 

 

Weighted Average Exercise Price

 

 

Weighted Average Remaining Contractual Term

 

Aggregate Intrinsic Value

December 31, 2022

 

Grants outstanding

 

 

2,843,342

 

 

$

6.66

 

 

 

 

 

 

Grants exercised

 

 

(394,375

)

 

$

6.06

 

 

 

 

 

 

Grants cancelled/forfeited

 

 

(533,715

)

 

$

6.68

 

 

 

 

 

December 31, 2023

 

Grants outstanding

 

 

1,915,252

 

 

$

5.15

 

 

6.2 Years

 

$21.9 million

December 31, 2023

 

Grants vested

 

 

518,455

 

 

$

5.13

 

 

6.1 Years

 

$5.9 million

December 31, 2023

 

Grants unvested

 

 

1,396,797

 

 

$

5.16

 

 

 

 

 

A summary of changes in outstanding options and the related weighted-average exercise price per share for the years ended December 31, 2022 and 2021 is as follows:

 

 

December 31,

 

 

 

2022

 

 

2021

 

 

 

Options

 

 

Weighted Average Exercise Price

 

 

Options

 

 

Weighted Average Exercise Price

 

Grants outstanding at the beginning of the year

 

 

3,519,563

 

 

$

6.66

 

 

 

 

 

$

 

Grants issued in exchange for options in the Company’s Parent

 

 

 

 

$

 

 

 

3,938,491

 

 

$

6.65

 

Grants exercised

 

 

(372,254

)

 

$

6.68

 

 

 

(58,552

)

 

$

6.61

 

Grants cancelled/forfeited

 

 

(303,967

)

 

$

6.61

 

 

 

(360,376

)

 

$

6.61

 

Grants outstanding at the end of the year

 

 

2,843,342

 

 

$

6.66

 

 

 

3,519,563

 

 

$

6.66

 

Grants vested

 

 

648,926

 

 

$

6.65

 

 

 

681,227

 

 

$

6.66

 

Grants unvested

 

 

2,194,416

 

 

$

6.67

 

 

 

2,838,336

 

 

$

6.66

 

 

2021 Equity Plan [Member]  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Summary of Assumptions Applied to Establish Fair Value of Options Granted Using Black-Scholes Option Pricing Model

The fair value for stock options granted for the years ended December 31, 2023, 2022, and 2021 was estimated at the date of grant using the Black-Scholes option-pricing model with the following weighed average assumptions:

 

 

Year Ended December 31,

 

 

 

2023

 

 

2022

 

 

2021

 

Expected stock price volatility

 

 

32.99

%

 

 

34.66

%

 

 

38.67

%

Risk-free interest rate

 

 

4.00

%

 

 

2.77

%

 

 

1.06

%

Expected term (in years)

 

 

6.78

 

 

 

6.23

 

 

 

5.91

 

Fair-value of the underlying unit

 

$

12.56

 

 

$

14.68

 

 

$

15.33

 

Summary of Option Unit Activity

A summary of the option activity for the year ended December 31, 2023 is as follows:

 

 

 

Options

 

 

Weighted Average Exercise Price

 

 

Weighted Average Remaining Contractual Term

 

Aggregate Intrinsic Value

December 31, 2022

 

Grants outstanding

 

 

4,311,662

 

 

$

15.24

 

 

 

 

 

 

 

Grants issued

 

 

579,745

 

 

$

12.56

 

 

 

 

 

 

 

Grants exercised

 

 

(22,402

)

 

$

12.55

 

 

 

 

 

 

 

Grants cancelled/forfeited

 

 

(182,346

)

 

$

13.81

 

 

 

 

 

December 31, 2023

 

Grants outstanding

 

 

4,686,659

 

 

$

13.61

 

 

7.8 Years

 

$13.9 million

December 31, 2023

 

Grants vested

 

 

1,600,529

 

 

$

13.76

 

 

7.6 Years

 

$4.5 million

December 31, 2023

 

Grants unvested

 

 

3,086,130

 

 

$

13.53

 

 

 

 

 

A summary of changes in outstanding options and the related weighted-average exercise price per share for the years ended December 31, 2022 and 2021 is as follows:

 

 

December 31,

 

 

 

2022

 

 

2021

 

 

 

Options

 

 

Weighted Average Exercise Price

 

 

Options

 

 

Weighted Average Exercise Price

 

Grants outstanding at the beginning of the year

 

 

3,714,540

 

 

$

15.33

 

 

 

 

 

$

 

Grants issued

 

 

608,122

 

 

$

14.68

 

 

 

3,714,540

 

 

$

15.33

 

Grants cancelled/forfeited

 

 

(11,000

)

 

$

17.52

 

 

 

 

 

$

 

Grants outstanding at the end of the year

 

 

4,311,662

 

 

$

15.24

 

 

 

3,714,540

 

 

$

15.33

 

Grants vested

 

 

1,054,302

 

 

$

15.20

 

 

 

644,556

 

 

$

15.00

 

Grants unvested

 

 

3,257,360

 

 

$

15.25

 

 

 

3,069,984

 

 

$

15.40

 

 

Summary of the RSU activity

A summary of the RSU activity for the years ended December 31, 2023, 2022, and 2021 is as follows:

 

 

 

Shares

 

 

Weighted Average Grant Date Fair Value

 

December 31, 2020

 

Nonvested RSUs

 

 

 

 

$

 

 

Granted

 

 

340,875

 

 

$

17.19

 

December 31, 2021

 

Nonvested RSUs

 

 

340,875

 

 

$

17.19

 

 

Granted

 

 

203,032

 

 

$

14.36

 

 

Vested

 

 

(67,175

)

 

$

16.96

 

 

 

Forfeited

 

 

(4,400

)

 

$

17.52

 

December 31, 2022

 

Nonvested RSUs

 

 

472,332

 

 

$

16.00

 

 

Granted

 

 

235,903

 

 

$

13.46

 

 

Vested

 

 

(150,724

)

 

$

15.42

 

 

 

Forfeited

 

 

(50,368

)

 

$

14.90

 

December 31, 2023

 

Nonvested RSUs

 

 

507,143

 

 

$

15.10

 

2021 Equity Plan [Member] | Restricted Stock  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Summary of Restricted Stock Activity

A summary of the restricted stock activity for the years ended December 31, 2023, 2022, and 2021 is as follows:

 

 

 

Shares

 

 

Weighted Average
Grant Date Fair Value

 

December 31, 2020

 

Nonvested restricted stock

 

 

 

 

$

 

 

 

Grants issued in exchange for unvested profits interests in the Company’s Parent

 

 

2,918,084

 

 

$

3.85

 

 

 

Vested

 

 

(304,725

)

 

$

3.85

 

December 31, 2021

 

Nonvested restricted stock

 

 

2,613,359

 

 

$

3.85

 

 

 

Vested

 

 

(332,059

)

 

$

3.85

 

December 31, 2022

 

Nonvested restricted stock

 

 

2,281,300

 

 

$

3.85

 

 

Vested

 

 

(326,670

)

 

$

3.85

 

December 31, 2023

 

Nonvested restricted stock

 

 

1,954,630

 

 

$

8.50

 

Successor Plan [Member]  
Share Based Compensation Arrangement By Share Based Payment Award [Line Items]  
Summary of the Profits Interest Activity

A summary of the profits interest unit activity under the 2020 Equity Plan for the year ended December 31, 2021 is as follows:

 

 

 

Class C Units

 

December 31, 2020

 

Grants outstanding

 

 

3,858,048

 

 

Exchanged for common stock in the Company

 

 

(411,720

)

 

 

Exchanged for restricted stock in the Company

 

 

(3,446,328

)

December 31, 2021

 

Grants outstanding

 

 

 

 

Summary of Option Unit Activity

A summary of the option unit activity under the 2020 Plan for the year ended December 31, 2021 is as follows:

 

 

 

Options

 

 

Weighted Average Exercise Price

 

December 31, 2020

 

Grants outstanding

 

 

2,733,734

 

 

$

10.06

 

 

Exercised

 

 

(24,112

)

 

$

10.00

 

 

 

Forfeited

 

 

(107,168

)

 

$

10.00

 

 

Exchanged for options in the Company

 

 

(2,602,454

)

 

$

10.07

 

December 31, 2021

 

Grants outstanding

 

 

 

 

$

 

In connection with the Company’s IPO, the Company’s parent was dissolved. Awards issued by the Company’s parent were converted in accordance with non-discretionary anti-dilution provisions of the 2020 Equity Plan grants as follows: